MedTrace Logo

Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)

NCT00706082 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 490

Last updated 2012-06-25

No results posted yet for this study

Summary

A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary hypertension

Conditions

Sponsors & Collaborators

  • Actelion

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-11-30
Completion
2012-03-31

Countries

  • United States
  • Austria
  • Bosnia and Herzegovina
  • Brazil
  • Canada
  • China
  • Czechia
  • Germany
  • Hungary
  • Netherlands
  • Norway
  • Poland
  • Puerto Rico
  • Romania
  • Russia
  • Slovakia
  • Spain
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00706082 on ClinicalTrials.gov